The DEA’s anticipated extension of telehealth prescribing flexibility once again averts an immediate disruption in care, but it leaves providers and patients in the same cycle of uncertainty that has persisted for years.
While the FDA promised decisions on unique identifiers by the end of June, according to Modern Healthcare, it’s still under “administrative review.” The FDA has received an open letter to the Office of Management and Budget urging them to push the regulations through and to shorten its proposed seven-year time frame from the Advancing Patient […]
Greenway Health blends smart technology with human expertise to elevate revenue cycle.